CG Oncology (CGON) Other Working Capital Changes (2025 - 2026)

CG Oncology's Other Working Capital Changes history runs 2 years deep, the most recent figure standing at -$329000.0 for Q1 2026.

• Quarterly Other Working Capital Changes rose 2751.43% year-over-year to $998000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 million (down 50.33% YoY) and the FY2025 annual result came in at $1.9 million, down 67.03% from the prior year.
• Other Working Capital Changes was -$329000.0 for Q1 2026 at CG Oncology, up from -$496000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $4.4 million in Q2 2024 and bottomed at -$320000.0 in Q3 2023.
• A 4-year average of $720583.3 and a median of $290500.0 in 2024 frame the typical range for Other Working Capital Changes.
• Annual changes were most pronounced in 2025 — Other Working Capital Changes slumped 101.13% — and 2026, when it soared 2751.43%.
• CG Oncology's Other Working Capital Changes stood at -$320000.0 in 2023, then jumped by 363.12% to $842000.0 in 2024, then surged by 114.96% to $1.8 million in 2025, then sank by 44.86% to $998000.0 in 2026.
• Business Quant data shows CGON's Other Working Capital Changes at $998000.0 in Q1 2026, $1.8 million in Q4 2025, and $105000.0 in Q3 2025.